On September 19, Lbx Pharmacy Chain Joint Stock surged, followed by Yifeng Pharmacy Chain, Yunnan Jianzhijia Health-chain, Yixintang Pharmaceutical, and Shuyu Pingmin. Guosheng Securities' research report pointed out that the concentration of the pharmacy industry has increased and the trend of prescription drugs flowing out has not changed. With the aging population, leading pharmacy chains are expected to have stable and robust development. Looking ahead to 2024, the integration of outpatient clinics is expected to contribute significant growth, driving further increases in customer traffic and gross profit for pharmacies.